Flecainide treats a novel KCNJ2 mutation associated with Andersen-Tawil syndrome

HeartRhythm Case Reports

Elise C. McCune¹  Lee L. Eckhardt, MD, FHRS¹  Hanora A. Van Ert, BSN¹  Craig T. January, MD, PhD¹  Nicholas H. Von Bergen, MD²  Kate M. Orland, MS²  Kathleen R. Maginot, MD² 

[1] Cellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Madison, Wisconsin;University of Wisconsin-Madison Inherited Arrhythmia Clinic, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin;

关键词: Genetic arrhythmia syndrome;    Andersen-Tawil syndrome/long QT 7;    KCNJ2 mutation;    Ventricular arrhythmia–bidirectional ventricular tachycardia;    Antiarrhythmic drugs;   

DOI  :  10.1016/j.hrcr.2016.11.009

来源: DOAJ

【 授权许可】

Unknown